After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Hims & Hers Health Inc is listed on the NYSE as a member of the Consumer Defensive sector and is a part of the Household & Personal Products industry. The current market capitalization of Hims & Hers Health Inc is $2.83B. A total of 12.79 million shares were traded on the day, compared to an average of 3.33M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, HIMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 73 BUYs and 99 SELLs from insiders. Insiders purchased 3,211,962 shares during that period but sold 12,639,425.
In the most recent transaction, Becklund Irene sold 2,747 shares of HIMS for 12.08 per share on Feb 27. After the transaction, the PAO now owns 5,494 company shares. In a previous transaction on Feb 15, Boughton Soleil sold 5,972 shares at 10.04 per share. HIMS shares that Chief Legal Officer owns now total 154,345.
Among the insiders who sold shares, Dudum Andrew disposed of 77,382 shares on Feb 14 at a per-share price of $9.90. This resulted in the Chief Executive Officer holding 51,653 shares of HIMS after the transaction. In another insider transaction, Boughton Soleil sold 17,109 shares at $10.00 per share on Feb 14. Company shares held by the Chief Legal Officer now total 154,345.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for HIMS in the last 3 months, the mean price target is $13.45 with high estimates of $17.00 and low estimates of $7.00. In terms of 52-week highs and lows, HIMS has a high of $13.91 and a low of $5.65.
As of this writing, HIMS has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.04. The company reported an EPS of -$0.04 in the last quarter, which was -33.30% lower than expectations of -$0.03.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $1.61, while its Total Shareholder’s Equity was $334.62M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 3.92.
